Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
复制标题
DOI:
10.1126/scisignal.aak9702
复制
发表时间:
2017-08-29
影响因子:
7.3
通讯作者:
Wolchok JD
中科院分区:
文献类型:
--
作者:
Budhu S;Schaer DA;Li Y;Toledo-Crow R;Panageas K;Yang X;Zhong H;Houghton AN;Silverstein SC;Merghoub T;Wolchok JD
Regulatory T cells (Tregs) suppress antitumor immunity by inhibiting the killing of tumor cells by antigen-specific CD8+ T cells. To better understand the mechanisms involved, we used ex vivo three-dimensional (3D) collagen-fibrin gel cultures of dissociated B16 melanoma tumors. This system recapitulated the in vivo suppression of antimelanoma immunity, rendering the dissociated tumor cells resistant to killing by cocultured activated, antigen-specific T cells. Immunosuppression was not observed when tumors excised from Treg-depleted mice were cultured in this system. Experiments with neutralizing antibodies showed that blocking transforming growth factor–β (TGF-β) also prevented immunosuppression. Immunosuppression depended on cell-cell contact or cellular proximity because soluble factors from the collagen-fibrin gel cultures did not inhibit tumor cell killing by T cells. Moreover, intravital, two-photon microscopy showed that tumor-specific Pmel-1 effector T cells physically interacted with tumor-resident Tregs in mice. Tregs isolated from B16 tumors alone were sufficient to suppress CD8+ T cell–mediated killing, which depended on surface-bound TGF-β on the Tregs. Immunosuppression of CD8+ T cells correlated with a decrease in the abundance of the cytolytic protein granzyme B and an increase in the cell surface amount of the immune checkpoint receptor PD-1. These findings suggest that contact between Tregs and antitumor T cells in the tumor microenvironment inhibits antimelanoma immunity in a TGF-β–dependent manner and highlight potential ways to inhibit intratumoral Tregs therapeutically.
登录
查看更多内容
影响因子:
3.7
作者:
Schaer, David A.;Li, Yongbiao;Wolchok, Jedd D.
通讯作者:
Wolchok, Jedd D.
影响因子:
11.2
作者:
Lesokhin AM;Hohl TM;Kitano S;Cortez C;Hirschhorn-Cymerman D;Avogadri F;Rizzuto GA;Lazarus JJ;Pamer EG;Houghton AN;Merghoub T;Wolchok JD
通讯作者:
Wolchok JD
影响因子:
10.1
作者:
Schaer DA;Budhu S;Liu C;Bryson C;Malandro N;Cohen A;Zhong H;Yang X;Houghton AN;Merghoub T;Wolchok JD
通讯作者:
Wolchok JD
DOI:
10.1084/jem.20082205
发表时间:
2009-05-11
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hirschhorn-Cymerman D;Rizzuto GA;Merghoub T;Cohen AD;Avogadri F;Lesokhin AM;Weinberg AD;Wolchok JD;Houghton AN
通讯作者:
Houghton AN
影响因子:
32.4
作者:
Mempel, Thorsten R.;Pittet, Mikael J.;von Andrian, Ulrich H.
通讯作者:
von Andrian, Ulrich H.